Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. This segment also engages in the real estate leasing and facility management, and hotel management operations. The Prescription Pharmaceutical Operation Group segment offers ethical drugs, including Edirol, an active vitamin D3 osteoporosis agent; Clarith, a macrolide antibiotic; Palux, a peripheral vasodilator; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. This segment has various products under development primarily in therapeutic areas, such as central nervous system, infectious, and metabolic diseases, as well as orthopedic disorders. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan.
Taisho Pharmaceutical Dividend Announcement
• Taisho Pharmaceutical announced a semi annually dividend of $0.09 per ordinary share which will be made payable on 2023-12-18. Ex dividend date: 2023-09-28
• Taisho Pharmaceutical annual dividend for 2023 was $0.17
• Taisho Pharmaceutical's trailing twelve-month (TTM) dividend yield is -%
Taisho Pharmaceutical Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2023-09-28 | $0.09 | semi annually | 2023-12-18 |
| 2023-03-30 | $0.09 | semi annually | 2023-07-17 |
| 2022-09-29 | $0.09 | semi annually | 2022-12-19 |
| 2022-03-29 | $0.09 | semi annually | 2022-07-15 |
| 2021-09-28 | $0.11 | semi annually | 2021-12-17 |
| 2021-03-29 | $0.11 | semi annually | 2021-07-15 |
Taisho Pharmaceutical Dividend per year
Taisho Pharmaceutical Dividend growth
Taisho Pharmaceutical Dividend Yield
Taisho Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Taisho Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Taisho Pharmaceutical Financial Ratios
P/E ratio16.83
PEG ratio-0.09
P/B ratio0.21
ROE1.26%
Payout ratio0.00%
Current ratio5.16
Quick ratio4.37
Cash Ratio3.04
Taisho Pharmaceutical Dividend FAQ
How much is the next Taisho Pharmaceutical dividend?
Taisho Pharmaceutical's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Taisho Pharmaceutical dividend. The next Taisho Pharmaceutical dividend will be released in March, or September.
When is Taisho Pharmaceutical dividend paid?
Taisho Pharmaceutical pays dividends on a semi annually basis. The specific dates may vary each year but are generally around March, and September. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Taisho Pharmaceutical pay?
The specific amount of Taisho Pharmaceutical dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Taisho Pharmaceutical's dividend history.
Does Taisho Pharmaceutical stock pay dividends?
Yes, Taisho Pharmaceutical does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Taisho Pharmaceutical's dividend history.
How much dividend does Taisho Pharmaceutical pay?
Taisho Pharmaceutical paid $0.0 in 2024, $0.172 in 2023, $0.183 in 2022, $0.223 in 2021, and $0.0 in 2020.
How often does Taisho Pharmaceutical pay dividends?
Taisho Pharmaceutical typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around March, and September.
What is Taisho Pharmaceutical's dividend yield?
The current dividend yield for Taisho Pharmaceutical is -%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Taisho Pharmaceutical's exact dividend yield.
When does Taisho Pharmaceutical go ex dividend?
Taisho Pharmaceutical's ex-dividend date for the latest dividend was on 2023-09-28. Taisho Pharmaceutical typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Taisho Pharmaceutical dividend paid?
Taisho Pharmaceutical pays dividends on a semi annually basis, typically around March, or September, but the exact dates can vary each year.
Will Taisho Pharmaceutical increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Taisho Pharmaceutical will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Taisho Pharmaceutical dividend per share?
Taisho Pharmaceutical paid $0.0 per share in 2024 and $0.172 per share in 2023. The amount of dividend per share that Taisho Pharmaceutical pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Taisho Pharmaceutical a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Taisho Pharmaceutical a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Taisho Pharmaceutical a dividend stock?
Yes, Taisho Pharmaceutical is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Taisho Pharmaceutical a good dividend stock?
Whether Taisho Pharmaceutical is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Taisho Pharmaceutical has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Taisho Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating Taisho Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Taisho Pharmaceutical pay dividends monthly?
Taisho Pharmaceutical typically pays dividends on a semi annually basis.
Does Taisho Pharmaceutical pay dividends quarterly?
Taisho Pharmaceutical currently pays dividends on a semi annually basis.
Has Taisho Pharmaceutical ever paid a dividend?
Yes, Taisho Pharmaceutical has a history of paying dividends to its shareholders. Taisho Pharmaceutical is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Taisho Pharmaceutical dividend stocks?
To buy Taisho Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Taisho Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Taisho Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Taisho Pharmaceutical pay dividends 2024?
Taisho Pharmaceutical pays dividends on a semi annually basis. 2024 dividend payments are in 2023-12-18. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Taisho Pharmaceutical increase its dividend in 2024?
Decisions regarding Taisho Pharmaceutical dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Taisho Pharmaceutical dividend overview you can look into the above table of dividend history.
How Taisho Pharmaceutical dividend works?
The Taisho Pharmaceutical dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Taisho Pharmaceutical's dividend process works:
1. Determination of Dividend: Taisho Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Taisho Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Taisho Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Taisho Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: Taisho Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Taisho Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Taisho Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Taisho Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Taisho Pharmaceutical dividends paid?
Taisho Pharmaceutical dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Taisho Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Taisho Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Taisho Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: Taisho Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Taisho Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Taisho Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Taisho Pharmaceutical pay dividends?
Taisho Pharmaceutical typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Taisho Pharmaceutical pay dividends?
The general pattern is that Taisho Pharmaceutical pays dividends around March, and September. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Taisho Pharmaceutical dividend safe?
The safety of Taisho Pharmaceutical's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Taisho Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Taisho Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of Taisho Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Taisho Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.